A citation-based method for searching scientific literature

Emma G Wilmot, Pratik Choudhary, Lalantha Leelarathna, Mike Baxter. Diabetes Obes Metab 2019
Times Cited: 3







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
345
66

Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes.
Thomas Danne, Jeremy Pettus, Andrea Giaccari, Bertrand Cariou, Helena Rodbard, Stuart A Weinzimer, Mireille Bonnemaire, Sangeeta Sawhney, John Stewart, Stella Wang,[...]. Diabetes Technol. Ther. 2019
3
33

SGLT-2 Inhibitors and GLP-1 Agonists: First-Line Therapy for Diabetes With Established Cardiovascular Disease.
Aparna P Sajja, Amit K Dey, Avirup Guha, Youssef Elnabawi, Aditya A Joshi, Ankur Kalra. J. Cardiovasc. Pharmacol. Ther. 2019
3
33


Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program.
David R Matthews, Qiang Li, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Mehul Desai, William R Hiatt, Mark Nehler, Elisa Fabbrini,[...]. Diabetologia 2019
29
33

HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study.
Thomas Danne, Bertrand Cariou, Phillip Banks, Michael Brandle, Helmut Brath, Edward Franek, Jake A Kushner, Pablo Lapuerta, Darren K McGuire, Anne L Peters,[...]. Diabetes Care 2018
55
33

Exploring Patient Preferences for Adjunct-to-Insulin Therapy in Type 1 Diabetes.
Bruce A Perkins, Julio Rosenstock, Jay S Skyler, Lori M Laffel, David Z Cherney, Chantal Mathieu, Christianne Pang, Richard Wood, Ona Kinduryte, Jyothis T George,[...]. Diabetes Care 2019
2
50

The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes.
Daniël H van Raalte, Petter Bjornstad, Frederik Persson, David R Powell, Rita de Cassia Castro, Ping Stella Wang, Minzhi Liu, Hiddo J L Heerspink, David Cherney. Diabetes Care 2019
7
33


Type 1 diabetes mellitus.
Anastasia Katsarou, Soffia Gudbjörnsdottir, Araz Rawshani, Dana Dabelea, Ezio Bonifacio, Barbara J Anderson, Laura M Jacobsen, Desmond A Schatz, Åke Lernmark. Nat Rev Dis Primers 2017
170
33



Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study.
John B Buse, Satish K Garg, Julio Rosenstock, Timothy S Bailey, Phillip Banks, Bruce W Bode, Thomas Danne, Jake A Kushner, Wendy S Lane, Pablo Lapuerta,[...]. Diabetes Care 2018
68
33

Dose-dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12 weeks: The inTandem4 trial.
Claire Baker, Suman Wason, Phillip Banks, Sangeeta Sawhney, Anna Chang, Thomas Danne, Diane Gesty-Palmer, Jake A Kushner, Darren K McGuire, Frank Mikell,[...]. Diabetes Obes Metab 2019
6
33

Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program.
Thomas Danne, Bertrand Cariou, John B Buse, Satish K Garg, Julio Rosenstock, Phillip Banks, Jake A Kushner, Darren K McGuire, Anne L Peters, Sangeeta Sawhney,[...]. Diabetes Care 2019
19
33

Hyperglycemic crises in adult patients with diabetes.
Abbas E Kitabchi, Guillermo E Umpierrez, John M Miles, Joseph N Fisher. Diabetes Care 2009
559
33

Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.
Kellee M Miller, Nicole C Foster, Roy W Beck, Richard M Bergenstal, Stephanie N DuBose, Linda A DiMeglio, David M Maahs, William V Tamborlane. Diabetes Care 2015
619
33

Adjunct Therapy in Type 1 Diabetes: A Survey to Uncover Unmet Needs and Patient Preferences Beyond HbA1c Measures.
Jeremy H Pettus, Jake A Kushner, Virginia Valentine, Richard Wood, Christianne Pang, Sachin Paranjape, Rachele Berria, Antonio Deluzio, Steven E Edelman. Diabetes Technol. Ther. 2019
1
100

Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives.
Chiara Maria Assunta Cefalo, Francesca Cinti, Simona Moffa, Flavia Impronta, Gian Pio Sorice, Teresa Mezza, Alfredo Pontecorvi, Andrea Giaccari. Cardiovasc Diabetol 2019
18
33

Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison.
J A McKnight, S H Wild, M J E Lamb, M N Cooper, T W Jones, E A Davis, S Hofer, M Fritsch, E Schober, J Svensson,[...]. Diabet. Med. 2015
132
33

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes.
Satish K Garg, Robert R Henry, Phillip Banks, John B Buse, Melanie J Davies, Gregory R Fulcher, Paolo Pozzilli, Diane Gesty-Palmer, Pablo Lapuerta, Rafael Simó,[...]. N. Engl. J. Med. 2017
139
33

LX4211, a dual SGLT1/SGLT2 inhibitor, improved glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial.
B Zambrowicz, J Freiman, P M Brown, K S Frazier, A Turnage, J Bronner, D Ruff, M Shadoan, P Banks, F Mseeh,[...]. Clin. Pharmacol. Ther. 2012
137
33

Insights Into Patients' Experience With Type 1 Diabetes: Exit Interviews From Phase III Studies of Sotagliflozin.
Claire Ervin, Vijay N Joish, Emily Evans, Dana DiBenedetti, Matthew Reaney, Ronald Preblick, Rita Castro, Thomas Danne, John B Buse, Pablo Lapuerta. Clin Ther 2019
1
100

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.
Thomas Danne, Satish Garg, Anne L Peters, John B Buse, Chantal Mathieu, Jeremy H Pettus, Charles M Alexander, Tadej Battelino, F Javier Ampudia-Blasco, Bruce W Bode,[...]. Diabetes Care 2019
56
33


Utilizing the Ambulatory Glucose Profile to Standardize and Implement Continuous Glucose Monitoring in Clinical Practice.
Mary L Johnson, Thomas W Martens, Amy B Criego, Anders L Carlson, Gregg D Simonson, Richard M Bergenstal. Diabetes Technol. Ther. 2019
6
33

A View Beyond HbA1c: Role of Continuous Glucose Monitoring.
Haleh Chehregosha, Mohammad E Khamseh, Mojtaba Malek, Farhad Hosseinpanah, Faramarz Ismail-Beigi.  2019
11
33

Potential Clinical Error Arising From Use of HbA1c in Diabetes: Effects of the Glycation Gap.
Ananth U Nayak, Baldev M Singh, Simon J Dunmore. Endocr. Rev. 2019
7
33

The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading.
Roy W Beck, Crystal G Connor, Deborah M Mullen, David M Wesley, Richard M Bergenstal. Diabetes Care 2017
89
33

Association between Inflammation and Biological Variation in Hemoglobin A1c in U.S. Nondiabetic Adults.
Shuqian Liu, James M Hempe, Robert J McCarter, Shengxu Li, Vivian A Fonseca. J. Clin. Endocrinol. Metab. 2015
20
33

Translating the A1C assay into estimated average glucose values.
David M Nathan, Judith Kuenen, Rikke Borg, Hui Zheng, David Schoenfeld, Robert J Heine. Diabetes Care 2008
724
33

Association of glycation gap with mortality and vascular complications in diabetes.
Ananth U Nayak, Alan M Nevill, Paul Bassett, Baldev M Singh. Diabetes Care 2013
22
33

The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial.
James M Hempe, Shuqian Liu, Leann Myers, Robert J McCarter, John B Buse, Vivian Fonseca. Diabetes Care 2015
62
33

Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring.
Dongyuan Xing, Craig Kollman, Roy W Beck, William V Tamborlane, Lori Laffel, Bruce A Buckingham, Darrell M Wilson, Stuart Weinzimer, Rosanna Fiallo-Scharer, Katrina J Ruedy. Diabetes Technol. Ther. 2011
37
33


High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control.
James M Hempe, Ricardo Gomez, Robert J McCarter, Stuart A Chalew. J. Diabetes Complicat. 2002
140
33


Progression of nephropathy in type 2 diabetes: the glycation gap is a significant predictor after adjustment for glycohemoglobin (Hb A1c).
Santiago Rodríguez-Segade, Javier Rodríguez, Jose M Cabezas-Agricola, Felipe F Casanueva, Félix Camiña. Clin. Chem. 2011
26
33

Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients.
Antonio Ceriello, Katherine Esposito, Ludovica Piconi, Michael A Ihnat, Jessica E Thorpe, Roberto Testa, Massimo Boemi, Dario Giugliano. Diabetes 2008
551
33

Continuous Glucose Monitoring: Review of an Innovation in Diabetes Management.
Zainab Mian, Kathie L Hermayer, Alicia Jenkins. Am. J. Med. Sci. 2019
5
33

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring.
Richard M Bergenstal, Roy W Beck, Kelly L Close, George Grunberger, David B Sacks, Aaron Kowalski, Adam S Brown, Lutz Heinemann, Grazia Aleppo, Donna B Ryan,[...]. Diabetes Care 2018
65
33



Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in type 1 and type 2 diabetic patients?
Judith C Kuenen, Rikke Borg, Dirk J Kuik, Hui Zheng, David Schoenfeld, Michaela Diamant, David M Nathan, Robert J Heine. Diabetes Care 2011
38
33

Glucose Management Indicator (GMI): Insights and Validation Using Guardian 3 and Navigator 2 Sensor Data.
Lalantha Leelarathna, Roy W Beck, Richard M Bergenstal, Hood Thabit, Roman Hovorka. Diabetes Care 2019
4
33

Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes.
Robert J McCarter, James M Hempe, Ricardo Gomez, Stuart A Chalew. Diabetes Care 2004
118
33


Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control.
Tonya D Riddlesworth, Roy W Beck, Robin L Gal, Crystal G Connor, Richard M Bergenstal, Sooji Lee, Steven M Willi. Diabetes Technol. Ther. 2018
39
33

GlyCulator2: an update on a web application for calculation of glycemic variability indices.
Konrad Pagacz, Konrad Stawiski, Agnieszka Szadkowska, Wojciech Mlynarski, Wojciech Fendler. Acta Diabetol 2018
6
33



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.